Showing results (51-60 of 181) with videos related to
Sort By:
Pageof 19
International Journal of Cancer|December 22, 1999
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEPR de Wit, M Louwerens, P H de Mulder, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic studyL T Vlasveld, J H Beynen, W Boogerd, et al.The International Journal of Artificial Organs|December 1, 1993
Peripheral blood stem cell (PBSC) mobilization and transplantation (PSCT) in patients with malignant lymphomas and solid tumorsD J Richel, E Van der Wall, J Slaper, et al.The Annals of Pharmacotherapy|April 1, 1992
Effect of cisplatin-containing chemotherapy on lithium serum concentrationsJ H Beijnen, L T Vlasveld, J Wanders, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Validation of a limited sampling model for carboplatin in a high-dose chemotherapy combinationL J van Warmerdam, S Rodenhuis, O van Tellingen, et al.British Journal of Cancer|September 19, 2002
Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCISN Bijker, J L Peterse, I S Fentiman, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2013
Outcomes of a population-based series of early breast cancer patients with micrometastases and isolated tumour cells in axillary lymph nodesM van der Heiden-van der Loo, M Schaapveld, V K Y Ho, et al.British Journal of Cancer|April 1, 1996
Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell supportL J van Warmerdam, S Rodenhuis, E van der Wall, et al.Cancer Chemotherapy and Pharmacology|January 1, 1983
Phase I clinical trial of (NPAz2)2NSOAz: 'SOAz'S Rodenhuis, N H Mulder, D T Sleijfer, et al.Journal of the National Cancer Institute|July 17, 1991
Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lungR J Slebos, R H Hruban, O Dalesio, et al.Pageof 19